Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | BMRN | SRPT | ||
| Company | Incyte Corp | Biomarin Pharmaceuticals | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 63.52 | 90.00 | 142.01 | ||
| High | 64.46 | 90.79 | 143.49 | ||
| Low | 63.05 | 89.37 | 140.41 | ||
| Last | 64.14 | 90.02 | 140.56 | ||
| Change | +1.12 | unch | -0.87 | ||
| % Change | +1.78% | unch | -0.62% | ||
| Volume | 1,566,700 | 1,262,400 | 510,400 | ||
| 20-Day Average Volume | 2,086,810 | 1,530,025 | 1,300,590 | ||
| Previous Close | 63.02 | 90.02 | 141.43 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 63.19 | 87.97 | 138.49 | ||
| 20-Day Raw Stochastic | 43.19% | 67.34% | 63.23% | ||
| 20-Day Relative Strength | 54.29% | 56.84% | 50.75% | ||
| Weighted Alpha | +6.12 | +0.14 | +19.24 | ||
| Today's Opinion | 88% Buy | 72% Buy | 56% Buy | ||
| Previous Opinion | 72% Buy | 56% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 24% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.19% since 08/16/24 | +0.55% since 08/16/24 | +5.32% since 08/16/24 | ||
| Low | 62.06 on 08/19/24 | 89.37 on 08/23/24 | 133.07 on 08/19/24 | ||
| High | 64.90 on 08/21/24 | 94.85 on 08/20/24 | 144.22 on 08/22/24 | ||
| 1-Month | |||||
| %Chg | -2.52% since 07/23/24 | +6.62% since 07/23/24 | -4.80% since 07/23/24 | ||
| Low | 60.19 on 08/08/24 | 80.06 on 08/05/24 | 123.50 on 08/09/24 | ||
| High | 70.36 on 07/25/24 | 94.85 on 08/20/24 | 150.48 on 07/29/24 | ||
| 3-Month | |||||
| %Chg | +11.64% since 05/23/24 | +18.60% since 05/23/24 | +10.56% since 05/23/24 | ||
| Low | 56.41 on 05/29/24 | 73.68 on 05/30/24 | 109.91 on 05/28/24 | ||
| High | 70.36 on 07/25/24 | 94.85 on 08/20/24 | 173.25 on 06/21/24 | ||
| 6-Month | |||||
| %Chg | +5.86% since 02/23/24 | -1.34% since 02/23/24 | +2.95% since 02/23/24 | ||
| Low | 50.35 on 04/30/24 | 73.68 on 05/30/24 | 109.91 on 05/28/24 | ||
| High | 70.36 on 07/25/24 | 94.85 on 08/20/24 | 173.25 on 06/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,402,060 | 17,092,998 | 13,286,294 | ||
| Shares Outstanding, K | 224,541 | 189,880 | 94,524 | ||
| Annual Sales | 3,695,650,000 | 2,419,230,000 | 1,243,340,000 | ||
| Annual Net Income | 597,600,000 | 167,650,000 | -535,980,000 | ||
| Last Quarter Sales | 1,043,760,000 | 712,030,000 | 362,930,000 | ||
| Last Quarter Net Income | -444,600,000 | 107,170,000 | 6,460,000 | ||
| 60-Month Beta | 0.73 | 0.32 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.82 on 07/30/24 | 0.96 on 08/05/24 | 0.07 on 08/07/24 | ||
| Latest Earnings Date | 07/30/24 | 08/05/24 | 08/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 787.75 | 50.57 | 307.46 | ||